Redox-active and redox-silent compounds: synergistic therapeutics in cancer

R Alleva, LF Dong, J Neuzil - Current Medicinal Chemistry, 2015 - ingentaconnect.com
Tumours exhibit higher basal levels of reactive oxygen species (ROS) and altered redox
environment compared to normal cells. Excessive level of ROS can be toxic to these cells …

Redox-active and redox-silent compounds: synergistic therapeutics in cancer

M Tomasetti, L Santarelli, R Alleva… - Current medicinal …, 2015 - pubmed.ncbi.nlm.nih.gov
Tumours exhibit higher basal levels of reactive oxygen species (ROS) and altered redox
environment compared to normal cells. Excessive level of ROS can be toxic to these cells …

Redox-active and redox-silent compounds: synergistic therapeutics in cancer

M Tomasetti, L Santarelli, R Alleva, LF Dong… - CURRENT …, 2014 - iris.univpm.it
Tumours exhibit higher basal levels of reactive oxygen species (ROS) and altered redox
environment compared to normal cells. Excessive level of ROS can be toxic to these cells …

Redox-active and redox-silent compounds: synergistic therapeutics in cancer.

M Tomasetti, L Santarelli, R Alleva… - Current Medicinal …, 2015 - europepmc.org
Tumours exhibit higher basal levels of reactive oxygen species (ROS) and altered redox
environment compared to normal cells. Excessive level of ROS can be toxic to these cells …

[PDF][PDF] Redox-active and Redox-silent Compounds: Synergistic Therapeutics in Cancer

M Tomasetti, L Santarelli, R Alleva… - Current Medicinal …, 2015 - researchgate.net
Tumours exhibit higher basal levels of reactive oxygen species (ROS) and altered redox
environment compared to normal cells. Excessive level of ROS can be toxic to these cells …